Evidence map›Paper›PMID 26212325›Full record

ArticleCell reports2015

Metabolic Interplay between Astrocytes and Neurons Regulates Endocannabinoid Action.

Andreu Viader, Jacqueline L Blankman, Peng Zhong, Xiaojie Liu, Joel E Schlosburg, Christopher M Joslyn, Qing-Song Liu, Aaron J Tomarchio, Aron H Lichtman, Dana E Selley and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 131 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. The biological functions of monoacylglycerol lipase (MAGL) in cancer.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2026
    Review
  6. Genetic Tools in Rodents to Study Cannabinoid Functions.Current topics in behavioral neurosciences · 2026
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Potential forBrain communications · 2024
    Article
  19. Review
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Andreu ViaderThe Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Chemical Physiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Jacqueline L BlankmanAbide Therapeutics, San Diego, CA 92121, USA.
Peng ZhongDepartment of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Xiaojie LiuDepartment of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Joel E SchlosburgCommittee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA 92037, USA.
Christopher M JoslynThe Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Chemical Physiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Qing-Song LiuDepartment of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Aaron J TomarchioDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA 23298, USA.
Aron H LichtmanDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA 23298, USA.
Dana E SelleyDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA 23298, USA.
Laura J Sim-SelleyDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA 23298, USA.
Benjamin F CravattThe Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Chemical Physiology, The Scripps Research Institute, La Jolla, CA 92037, USA. Electronic address: cravatt@scripps.edu.
Scripps Research Institute · USVirginia Commonwealth University · USMedical College of Wisconsin · US

Funding

VCU Center for Drug Addiction ResearchP30DA033934 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI YAN ZHANG · 2014 to 2026
$13.8M
CHEMOPROTEOMIC METHODS FOR SERINE HYDROLASE INHIBITOR DEVELOPMENTR01DA033760 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI CRAVATT, BENJAMIN F, SCAMPAVIA, LOUIS DANIEL · 2012 to 2021
$5.1M
Endocannabinoid modulation of pain-depressed behaviorR01DA030404 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI NEGUS, SIDNEY S, SIM-SELLEY, LAURA J · 2011 to 2020
$3.7M
Mechanistic studies of phosphodiesterase inhibitors in cocaine addictionR01DA035217 · NIDA · MEDICAL COLLEGE OF WISCONSIN · PI LIU, QING-SONG · 2014 to 2023
$3.4M
Monoacylglycerol Lipase Inhibitors for Treating Opioid Use Disorders (RO)R01DA032933 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI CRAVATT, BENJAMIN F, LICHTMAN, ARON H · 2012 to 2014
$1.5M
Regulation of dopamine neuronal activity and depressive behavior by HCN channelsR56MH101146 · NIMH · MEDICAL COLLEGE OF WISCONSIN · PI LIU, QING-SONG · 2014 to 2015
$765k
Treatment of Opiate Dependence through Inhibition of Fatty Acid Amide HydrolaseR00DA037344 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI SCHLOSBURG, JOEL EVAN · 2017 to 2019
$738k
Treatment of Opiate Dependence through Inhibition of Fatty Acid Amide HydrolaseK99DA037344 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI SCHLOSBURG, JOEL EVAN · 2014 to 2015
$284k
Lipidomic mapping of the cellular anatomy of brain endocannabinoid metabolismK01GM109315 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI VIADER, ANDREU · 2013 to 2015
$275k
NIDA NIH HHS DA032933NIDA NIH HHS DA033760NIDA NIH HHS DA035217NIDA NIH HHS DA037344NIDA NIH HHS K99 DA037344NIDA NIH HHS P30 DA033934NIDA NIH HHS R00 DA037344NIDA NIH HHS R01 DA030404NIDA NIH HHS R01 DA032933NIDA NIH HHS R01 DA033760NIDA NIH HHS R01 DA035217NIGMS NIH HHS GM109315NIGMS NIH HHS K01 GM109315NIMH NIH HHS MH101146NIMH NIH HHS R56 MH101146
6 · The paper itself

Abstract

The endocannabinoid 2-arachidonoylglycerol (2-AG) is a retrograde lipid messenger that modulates synaptic function, neurophysiology, and behavior. 2-AG signaling is terminated by enzymatic hydrolysis-a reaction that is principally performed by monoacylglycerol lipase (MAGL). MAGL is broadly expressed throughout the nervous system, and the contributions of different brain cell types to the regulation of 2-AG activity in vivo remain poorly understood. Here, we genetically dissect the cellular anatomy of MAGL-mediated 2-AG metabolism in the brain and show that neurons and astrocytes coordinately regulate 2-AG content and endocannabinoid-dependent forms of synaptic plasticity and behavior. We also find that astrocytic MAGL is mainly responsible for converting 2-AG to neuroinflammatory prostaglandins via a mechanism that may involve transcellular shuttling of lipid substrates. Astrocytic-neuronal interplay thus provides distributed oversight of 2-AG metabolism and function and, through doing so, protects the nervous system from excessive CB1 receptor activation and promotes endocannabinoid crosstalk with other lipid transmitter systems.

Indexed as

AnimalsArachidonic AcidsAstrocytesCell CommunicationEndocannabinoidsGlyceridesMiceMice, KnockoutMonoacylglycerol LipasesNeuronsReceptor, Cannabinoid, CB1Arachidonic AcidsEndocannabinoidsGlyceridesglyceryl 2-arachidonateMonoacylglycerol LipasesReceptor, Cannabinoid, CB1

Identifiers

PMID26212325
PMCPMC4526356
OpenAlexW1494787392

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.